Literature DB >> 29259504

The Rise and Fall of Estrogen Therapy: Is Testosterone for "Manopause" Next?

Briana T Costello, Keri Sprung, Stephanie A Coulter.   

Abstract

Entities:  

Keywords:  Age factors; aging/physiology; cardiovascular diseases/epidemiology/prevention & control; estrogen replacement therapy/adverse effects; factitious disorders; postmenopause; randomized controlled trials as topic; retrospective studies; risk factors; testosterone/administration & dosage/adverse effects/therapeutic use

Mesh：

Year:  2017        PMID： 29259504      PMCID： PMC5731587          DOI： 10.14503/THIJ-17-6360

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN： 0730-2347


× No keyword cloud information.
  15 in total

1.  Re: Testosterone Products: Drug Safety Communication - FDA Cautions about Using Testosterone Products for Low Testosterone due to Aging; Requires Labeling Change to Inform of Possible Increased Risk of Heart Attack and Stroke.

Authors:  Allen D Seftel
Journal:  J Urol       Date:  2015-06-18       Impact factor: 7.450

2.  Disease mongering of age-associated declines in testosterone and growth hormone levels.

Authors:  Thomas Perls; David J Handelsman
Journal:  J Am Geriatr Soc       Date:  2015-03-24       Impact factor: 5.562

Review 3.  Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline.

Authors:  Shalender Bhasin; Glenn R Cunningham; Frances J Hayes; Alvin M Matsumoto; Peter J Snyder; Ronald S Swerdloff; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2010-06       Impact factor: 5.958

4.  Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

Authors:  S Hulley; D Grady; T Bush; C Furberg; D Herrington; B Riggs; E Vittinghoff
Journal:  JAMA       Date:  1998-08-19       Impact factor: 56.272

5.  Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study.

Authors:  Frederick C W Wu; Abdelouahid Tajar; Stephen R Pye; Alan J Silman; Joseph D Finn; Terence W O'Neill; Gyorgy Bartfai; Felipe Casanueva; Gianni Forti; Aleksander Giwercman; Ilpo T Huhtaniemi; Krzysztof Kula; Margus Punab; Steven Boonen; Dirk Vanderschueren
Journal:  J Clin Endocrinol Metab       Date:  2008-02-12       Impact factor: 5.958

6.  Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels.

Authors:  Rebecca Vigen; Colin I O'Donnell; Anna E Barón; Gary K Grunwald; Thomas M Maddox; Steven M Bradley; Al Barqawi; Glenn Woning; Margaret E Wierman; Mary E Plomondon; John S Rumsfeld; P Michael Ho
Journal:  JAMA       Date:  2013-11-06       Impact factor: 56.272

7.  Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

Authors:  Deborah Grady; David Herrington; Vera Bittner; Roger Blumenthal; Michael Davidson; Mark Hlatky; Judith Hsia; Stephen Hulley; Alan Herd; Steven Khan; L Kristin Newby; David Waters; Eric Vittinghoff; Nanette Wenger
Journal:  JAMA       Date:  2002-07-03       Impact factor: 56.272

8.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272

9.  Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men.

Authors:  William D Finkle; Sander Greenland; Gregory K Ridgeway; John L Adams; Melissa A Frasco; Michael B Cook; Joseph F Fraumeni; Robert N Hoover
Journal:  PLoS One       Date:  2014-01-29       Impact factor: 3.240

10.  Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials.

Authors:  Lin Xu; Guy Freeman; Benjamin J Cowling; C Mary Schooling
Journal:  BMC Med       Date:  2013-04-18       Impact factor: 8.775
View more
  1 in total

1.  Prophylactic effect of Trigonella foenum-graecum L. seed extract on inflammatory markers and histopathological changes in high-fat-fed ovariectomized rats.

Authors:  Takkella Nagamma; Anjaneyulu Konuri; Kumar Mr Bhat; Padmanabha Udupa; Guruprasad Rao; Yogendra Nayak
Journal:  J Tradit Complement Med       Date:  2021-07-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.